Hotel Lotte Joins Lotte Biologics' $195M Capital Raise in August

According to Korea's Financial Supervisory Service, Hotel Lotte will participate in Lotte Biologics' seventh capital increase of 253.5 billion won (approximately $195 million) scheduled for August. The funding targets construction of a biopharmaceutical campus facility in Songdo. Hotel Lotte will take a 19.07% stake alongside existing shareholders Lotte Holdings (60.74%) and Japan's Lotte Holdings (20.11%). Analysts suggest the move aims to diversify Lotte Group's investment burden while positioning Hotel Lotte as a core holding company for future strategic restructuring.
Disclaimer: The information on this page may come from third-party sources and is for reference only. It does not represent the views or opinions of Gate and does not constitute any financial, investment, or legal advice. Virtual asset trading involves high risk. Please do not rely solely on the information on this page when making decisions. For details, see the Disclaimer.
Comment
0/400
No comments